Vanguard Group
OM icon

Vanguard Group’s Outset Medical OM Stock Holding History

Vanguard Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.63M Sell
977,969
-4,649
-0.5% -$39.9K ﹤0.01% 3373
2025
Q3 		$13.9M Sell
982,618
-8,811
-0.9% -$137K ﹤0.01% 2803
2025
Q2 		$19M Buy
991,429
+818,104
+472% +$12.8M ﹤0.01% 2581
2025
Q1 		$1.92M Sell
173,325
-602
-0.3% -$7.18K ﹤0.01% 3504
2024
Q4 		$2.9M Sell
173,927
-2,375
-1% -$29.6K ﹤0.01% 3456
2024
Q3 		$1.79M Sell
176,302
-98
-0.1% -$2.92K ﹤0.01% 3593
2024
Q2 		$10.2M Sell
176,400
-16,481
-9% -$808K ﹤0.01% 2906
2024
Q1 		$6.42M Sell
192,881
-69,877
-27% -$3.54M ﹤0.01% 3190
2023
Q4 		$21.3M Sell
262,758
-55,208
-17% -$4.49M ﹤0.01% 2567
2023
Q3 		$51.9M Buy
317,966
+1,450
+0.5% +$342K ﹤0.01% 2121
2023
Q2 		$104M Buy
316,516
+5,515
+2% +$1.68M ﹤0.01% 1828
2023
Q1 		$85.8M Buy
311,001
+5,691
+2% +$2.09M ﹤0.01% 1898
2022
Q4 		$118M Buy
305,310
+5,900
+2% +$1.66M ﹤0.01% 1716
2022
Q3 		$71.5M Buy
299,410
+9,792
+3% +$2.62M ﹤0.01% 1995
2022
Q2 		$64.6M Buy
289,618
+1,347
+0.5% +$579K ﹤0.01% 2072
2022
Q1 		$196M Buy
288,271
+12,677
+5% +$7.63M ﹤0.01% 1568
2021
Q4 		$191M Buy
275,594
+8,678
+3% +$6.42M ﹤0.01% 1641
2021
Q3 		$198M Buy
266,916
+19,963
+8% +$13.6M ﹤0.01% 1620
2021
Q2 		$185M Buy
246,953
+160,451
+185% +$123M ﹤0.01% 1671
2021
Q1 		$70.6M Buy
86,502
+1,963
+2% +$1.51M ﹤0.01% 2127
2020
Q4 		$72.1M Buy
84,539
+39,313
+87% +$30.3M ﹤0.01% 2008
2020
Q3 		$33.9M Buy
+45,226
New +$37.1M ﹤0.01% 2214

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Vanguard Group's OM Position: Q4 2025 in Review

Vanguard Group reduced its Outset Medical (OM) stake by 0.47% in Q4 2025, selling an estimated $39.9K and leaving 977,969 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3373.

Vanguard Group first reported a position in OM in Q3 2020 and has held it in 22 quarters since. The position peaked at $198M in Q3 2021. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Vanguard Group held 977,969 shares of Outset Medical worth $3.63M as of Q4 2025.
  • Vanguard Group sold 4,649 Outset Medical shares in Q4 2025, an estimated $39.9K.
  • Outset Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3373 holding.
  • Vanguard Group first reported a position in Outset Medical in Q3 2020 and has held it in 22 quarters since.
  • Vanguard Group's Outset Medical position peaked at $198M in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.